Flextronics acquires Avail Medical Products
As a division of the Flextronics Medical segment, Avail will continue to operate as a stand-alone business. Dan Croteau, president, Flextronics Medical, said: “The acquisition of Avail expands
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.